Equity Research, Broker Reports, and media content on Diurnal Group

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Diurnal Group
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Diurnal Group. We currently have 44 research reports from 3 professional analysts.

Open
N/A
Volume
N/A
Range Today
N/A
52 Week
28.5/214p
Market Cap
£17.8m
Enterprise Value
£103.5m
Pension Liability
£0m
# Shares
61.3m
Latest PE (hist)
Div Yield
Date Source Announcement
18Oct18 07:15 EQS Hardman & Co Research: Diurnal Group (DNL): Unexpected Phase III trial outcome
17Oct18 07:00 RNS Update on late-stage development pipeline
08Oct18 16:00 RNS Posting of Annual Report and AGM Notice
08Oct18 14:45 RNS SMC Approves The Use of Alkindi
08Oct18 07:00 RNS Headline Data for Chronocort European Phase III
05Oct18 07:00 RNS First patients enrolled in US Chronocort Phase III
20Sep18 07:00 RNS Results for the year ended 30 June 2018
  • Frequency of research reports

     

  • Research reports on

    Diurnal Group

  • Providers covering

    Diurnal Group